Frienson Pradhan | Molecular Biology | Young Scientist Award

Published on by Medical Lab Scientist

Mr. Frienson Pradhan | Molecular Biology | Young Scientist Award

Kathmandu University | Nepal

Mr. Frienson Pradhan is a biotechnology researcher with strong interdisciplinary training in molecular biology, microbiology, immunology, and bioinformatics, with a primary focus on translational and sustainability-driven research. His work spans host biomarker discovery, nature-based bioactive compounds, and applied environmental biotechnology. He has led and contributed to studies on circulating miR-1246 as a diagnostic and prognostic biomarker in dengue infection, integrating molecular diagnostics, RT-qPCR, and statistical correlation analyses, culminating in a peer-reviewed publication. His research portfolio further includes investigations into plant-derived antibacterial and biopesticidal agents, phylogenetic and domain analysis of bitter taste receptors (TAS2R), and physico-chemical and microbial assessment of drinking water quality. Actively engaged in collaborative and funded research initiatives, he has supported projects linking laboratory science with sustainable enterprise development. His research excellence has been internationally recognized through competitive scientific awards and global research forums, reflecting a strong commitment to impactful, innovation-driven biotechnology research.

View ORCID Profile

Featured Publications

Alina Ecaterina Jucan | Molecular Biology | Research Excellence Award

Published on by Medical Lab Scientist

Dr. Alina Ecaterina Jucan | Molecular Biology | Research Excellence Award

Doctor | University of Medicine and Pharmacy | Romania

Dr. Alina Ecaterina Jucan is a research-oriented scholar whose work contributes to the advancement of her field through focused investigation and peer-reviewed dissemination. Her academic output comprises 7 published documents, reflecting consistent engagement with scholarly research and evidence-based inquiry. These publications have collectively received 51 citations, indicating growing recognition and uptake of her findings within the research community. With an h-index of 4, her work demonstrates both productivity and measurable impact, highlighting publications that have achieved sustained citation performance. Her research emphasizes methodological rigor, analytical clarity, and relevance to current scientific and clinical questions, contributing to the broader body of knowledge and supporting translational relevance where applicable. Through her publications, she has addressed emerging challenges, refined existing concepts, and added incremental value to ongoing academic discourse. Her citation metrics underscore the visibility and influence of her research outputs, positioning her as an active contributor to her domain with a developing and credible scholarly profile grounded in peer-reviewed research excellence.

Citation Metrics (Scopus)

60

45

30

15

0

 

51
Citations

7
Documents

4
h-index

Citations

Documents

h-index

Featured Publications

Reza Bayat Mokhtari | Molecular Biology | Research Excellence Award

Published on by Medical Lab Scientist

Dr. Reza Bayat Mokhtari | Molecular Biology | Research Excellence Award

Director | Association of Clinical Immunology and Cancer Research | United States

Dr. Reza Bayat Mokhtari is a research-intensive biomedical scientist recognized for significant contributions to oncology and translational medicine, with a documented impact of 4,478 citations, an h-index of 20, and an i10-index of 30. The research portfolio focuses on molecular mechanisms of cancer progression, tumor microenvironment dynamics, and resistance to therapy, particularly in lung, breast, pancreatic, hepatic, and neuroendocrine malignancies. Core scientific contributions include studies on Hippo–YAP/TAZ signaling, Agrin-driven oncogenic processes, cancer stem cell regulation, hypoxia-associated pathways, and rational combination and repurposing strategies to improve immunotherapy outcomes. This body of peer-reviewed work bridges fundamental cancer biology with clinically relevant translational models, supporting biomarker development and precision oncology approaches. Overall, the scholarly output reflects sustained productivity, interdisciplinary scope, and measurable influence within the cancer research community.

Citation Metrics (Google Scholar)

6000

4500

3000

1500

0

 

4478
Citations

20
h-index

30
i10-index

Citations

h-index

i10-index

Featured Publications

Reza Bayat Mokhtari | Molecular Biology | Editorial Board Member

Published on by Medical Lab Scientist

Dr. Reza Bayat Mokhtari | Molecular Biology | Editorial Board Member

Director | Association of Clinical Immunology and Cancer Research | United States

Dr. Reza Bayat Mokhtari is a research-intensive biomedical scientist recognized for significant contributions to oncology and translational medicine, with a documented impact of 4,475 citations, an h-index of 20, and an i10-index of 30. The research portfolio focuses on molecular mechanisms of cancer progression, tumor microenvironment dynamics, and resistance to therapy, particularly in lung, breast, pancreatic, hepatic, and neuroendocrine malignancies. Core scientific contributions include studies on Hippo–YAP/TAZ signaling, Agrin-driven oncogenic processes, cancer stem cell regulation, hypoxia-associated pathways, and rational combination and repurposing strategies to improve immunotherapy outcomes. This body of peer-reviewed work bridges fundamental cancer biology with clinically relevant translational models, supporting biomarker development and precision oncology approaches. Overall, the scholarly output reflects sustained productivity, interdisciplinary scope, and measurable influence within the cancer research community.

Citation Metrics (Google Scholar)

6000

4500

3000

1500

0

 

4475
Citations

20
h-index

30
i10-index

Citations

h-index

i10-index

Featured Publications

Wenhe Lin | Genetics | Best Researcher Award

Published on by Medical Lab Scientist

Dr. Wenhe Lin | Genetics | Best Researcher Award

Wenhe Lin | University of Chicago | United States

Dr. Wenhe Lin is a researcher affiliated with the Department of Human Genetics at The University of Chicago, United States, whose scientific work focuses on uncovering the genetic and molecular mechanisms that regulate physiological responses to diet and environmental factors. His research contributes to a deeper understanding of how gene expression adapts to metabolic stress, offering insights into the biological foundations of complex diseases. Dr. Lin has published one peer-reviewed article titled “Genetic regulatory effects in response to a high-cholesterol, high-fat diet in baboons,” which appeared in Cell Genomics. This study highlights the interplay between nutrition and genetic regulation, addressing critical questions in metabolic and nutritional genomics. According to his Scopus author profile, Dr. Lin has authored 1 scientific document, which has received 10 citations, and maintains an h-index of 1, reflecting the early yet impactful nature of his academic contributions. His research approach integrates genomic sequencing, bioinformatics, and systems biology to explore gene–environment interactions that influence disease susceptibility. At The University of Chicago, he continues to advance research in human genetics with an emphasis on precision health and individualized nutrition strategies. Dr. Lin’s emerging body of work demonstrates strong potential to shape future investigations into metabolic regulation, genetic variability, and their implications for personalized medicine and human health.

Profiles: ORCID | Scopus | Google Scholar

Featured Publications

Irene Gómez | Molecular Biology | Best Researcher Award

Published on by Medical Lab Scientist

Dr. Irene Gómez | Molecular Biology | Best Researcher Award

Investigador Postdoctoral at Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Spain

Irene Gómez Delgado is a passionate and highly skilled postdoctoral researcher working at the Health Research Foundation of Clínico San Carlos Hospital, where she specializes in biomedicine, medical microbiology, and environmental risks. She has shown exceptional dedication to scientific discovery, focusing on the genetic and molecular basis of complex diseases, particularly in the area of immunology and nephrology. Irene’s collaborative spirit, commitment to rigorous methodology, and enthusiasm for public science engagement have marked her as an emerging leader in her field.

profile

orcid

Education

Irene Gómez Delgado’s academic journey reflects both excellence and depth, beginning with her Bachelor’s Degree in Biology from Universidad Complutense de Madrid, earned in 2016. She continued her academic pursuit with a Master’s Degree in Immunology Research from the same university in 2017, equipping her with advanced knowledge of immune system mechanisms. She culminated her formal education by earning a PhD in Molecular Bioscience at Universidad Autónoma de Madrid in 2022, where she developed a strong foundation in molecular biology, genetic research, and experimental design, all of which continue to influence her contributions to biomedical science.

Experience

Irene has steadily advanced her scientific career through key research roles, beginning as a predoctoral researcher at the Health Research Foundation of La Paz University Hospital from 2017 to 2022, where she gained comprehensive experience in molecular biology, laboratory supervision, and project execution. Since 2022, she has been working as a postdoctoral researcher at Clínico San Carlos Hospital’s Laboratory of Genetic and Molecular Basis of Complex Diseases. Alongside her research, Irene has co-directed Master’s Final Projects and supervised undergraduate students and laboratory technicians, showing strong leadership and mentorship capabilities.

Research Interest

Irene’s research interests lie primarily in understanding the molecular and genetic mechanisms underlying immunological and nephrological diseases. Her scientific focus includes studying complement system dysregulation, genetic variants related to immune system proteins, and mitochondrial alterations in immune cells. Her work also extends to infectious disease complications, including severe COVID-19 immune responses, making her research impactful for both rare disease understanding and global health challenges.

Award

Irene Gómez Delgado has been recognized for her scientific achievements through multiple awards. In 2023, she was honored with the Extraordinary Doctorate Award by Universidad Autónoma de Madrid, celebrating the outstanding quality and impact of her doctoral work. She also received the Poster Communication Award from the European Complement Network in 2022 for her contribution at the 18th European Meeting on Complement in Human Disease held in Bern, Switzerland. These awards highlight her scientific excellence and growing reputation in the immunology and nephrology research communities.

Publication

Dr. Gómez Delgado has co-authored several peer-reviewed scientific articles that contribute to the advancement of biomedical research.

Long term mitochondrial and metabolic impairment in lymphocytes of subjects who recovered after severe COVID-19 — published in 2025 in Cell Biology and Toxicology.

Tigecycline Opposes Bortezomib Effect on Myeloma Cells Decreasing Mitochondrial Reactive Oxygen Species Production — published in 2024 in International Journal of Molecular Sciences.

Complement Genetic Variants and FH Desialylation in S. pneumoniae-Haemolytic Uraemic Syndrome — published in 2021 in Frontiers in Immunology.

Low factor H-related 5 levels contribute to infection-triggered haemolytic uraemic syndrome and membranoproliferative glomerulonephritis — published in 2021 in Clinical Kidney Journal.

High Complement Factor H-Related (FHR)-3 Levels Are Associated With the Atypical Hemolytic-Uremic Syndrome-Risk Allele CFHR3*B — published in 2018 in Frontiers in Immunology.

Contribution of functional and quantitative genetic variants of Complement Factor H and Factor H-Related (FHR) proteins on renal pathology — published in 2022 in Nefrología.

Altered expression of FHR-1 and FHR-2 glycoforms in IgA nephropathy patients — published in 2024 in European Journal of Immunology (Meeting Abstract).

Conclusion

Dr. Irene Gómez Delgado exemplifies the qualities of a leading researcher through her pioneering contributions to immunology and molecular medicine, her active engagement in scientific dissemination, and her commitment to mentorship and collaborative research. Her career trajectory reflects an unwavering pursuit of knowledge and societal impact, which makes her a deserving and inspiring nominee for the Research for Best Researcher Award.